The Respiratory Effectiveness Group is an investigator-led, not-for-profit research initiative that has been set up in recognition of the potential value of real-life research and the need to harness real-life evidence to inform meaningful practice guidelines, drug licensing and prescribing decisions.
| Website | http://www.effectivenessevaluation.org/about-us/ |
| Employees | 7 (2 on RocketReach) |
| Technologies |
JavaScript
,
HTML
,
PHP
+16 more
(view full list)
|
| Industry | Research |
| Competitors | AstraZeneca, GSK, Novartis, Pfizer, Boehringer Ingelheim, Roche, Teva Pharmaceuticals, Mylan Belgium, Chiesi Group, Merck & Co., Inc. +36 more (view full list) |
Looking for a particular Respiratory Effectiveness Group employee's phone or email?
Respiratory Effectiveness Group Questions
Adam Marsh is the CEO of Respiratory Effectiveness Group.
2 people are employed at Respiratory Effectiveness Group.
Top Respiratory Effectiveness Group Employees
-
Adam Marsh
Chief Executive Officer at Respiratory Effectiveness Group
England, United Kingdom1
Related Companies
G2Crowd Trusted
300K+
Plugin Users
